Open Orphan has announced a contract with the UK Government to develop and perform the UK's first COVID-19 (COVID) human challenge studies. The multi-faceted agreement provides strong endorsement and validation of hVIVO's capabilities, with material revenues driving forecast upgrades and further upside risk to earnings as pipeline conversion continues and industry awareness and penetration of challenge studies accelerates.
20 Oct 2020
Open Orphan* - Material UK Government COVID Study Contract
hVIVO plc (OPORF:OTC), 0 | hVIVO plc (HVO:LON), 28.2 | hVIVO plc (CRO:FRA), 0 | hVIVO plc (HVO:DUB), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Open Orphan* - Material UK Government COVID Study Contract
hVIVO plc (OPORF:OTC), 0 | hVIVO plc (HVO:LON), 28.2 | hVIVO plc (CRO:FRA), 0 | hVIVO plc (HVO:DUB), 0
- Published:
20 Oct 2020 -
Author:
Andrew Simms -
Pages:
10
Open Orphan has announced a contract with the UK Government to develop and perform the UK's first COVID-19 (COVID) human challenge studies. The multi-faceted agreement provides strong endorsement and validation of hVIVO's capabilities, with material revenues driving forecast upgrades and further upside risk to earnings as pipeline conversion continues and industry awareness and penetration of challenge studies accelerates.